These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 17363700)

  • 21. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.
    Gogiraju R; Hubert A; Fahrer J; Straub BK; Brandt M; Wenzel P; Münzel T; Konstantinides S; Hasenfuss G; Schäfer K
    Circ Heart Fail; 2019 Jan; 12(1):e005622. PubMed ID: 30621510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
    Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
    Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
    Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
    Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase.
    Niu X; Watts VL; Cingolani OH; Sivakumaran V; Leyton-Mange JS; Ellis CL; Miller KL; Vandegaer K; Bedja D; Gabrielson KL; Paolocci N; Kass DA; Barouch LA
    J Am Coll Cardiol; 2012 May; 59(22):1979-87. PubMed ID: 22624839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle.
    Lu Z; Fassett J; Xu X; Hu X; Zhu G; French J; Zhang P; Schnermann J; Bache RJ; Chen Y
    Circulation; 2008 Oct; 118(17):1713-21. PubMed ID: 18838560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.
    Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
    J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative remodeling in pressure overload induced chronic heart failure.
    Henderson BC; Tyagi N; Ovechkin A; Kartha GK; Moshal KS; Tyagi SC
    Eur J Heart Fail; 2007 May; 9(5):450-7. PubMed ID: 17306621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.
    Jiang DS; Li L; Huang L; Gong J; Xia H; Liu X; Wan N; Wei X; Zhu X; Chen Y; Chen X; Zhang XD; Li H
    Hypertension; 2014 Jul; 64(1):77-86. PubMed ID: 24732887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts.
    Egi K; Conrad NE; Kwan J; Schulze C; Schulz R; Wildhirt SM
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):262-9. PubMed ID: 15296881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
    Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
    Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of inducible nitric oxide synthase provides cardioprotection in mice with 2-kidney, 1-clip hypertension.
    Sun Y; Carretero OA; Xu J; Rhaleb NE; Yang JJ; Pagano PJ; Yang XP
    Hypertension; 2009 Jan; 53(1):49-56. PubMed ID: 19001185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling.
    Zhang M; Takimoto E; Lee DI; Santos CX; Nakamura T; Hsu S; Jiang A; Nagayama T; Bedja D; Yuan Y; Eaton P; Shah AM; Kass DA
    Circulation; 2012 Aug; 126(8):942-51. PubMed ID: 22829024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
    Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
    Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction.
    Pacher P; Liaudet L; Bai P; Mabley JG; Kaminski PM; Virág L; Deb A; Szabó E; Ungvári Z; Wolin MS; Groves JT; Szabó C
    Circulation; 2003 Feb; 107(6):896-904. PubMed ID: 12591762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress.
    Hu A; Jiao X; Gao E; Koch WJ; Sharifi-Azad S; Grunwald Z; Ma XL; Sun JZ
    J Pharmacol Exp Ther; 2006 Aug; 318(2):469-75. PubMed ID: 16574780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.